The chief executive of the world's largest genomic sequencing technology company has called for global co-operation to track new virus variants, arguing it is essential to ensure that Covid-19 vaccines, drugs, and diagnostics do not fail in the face of new strains.
世界最大基因組測序技術公司Illumina的執行長呼籲全球合作追蹤病毒的新變種,主張有必要確保新型冠狀病毒肺炎(COVID-19,即2019冠狀病毒病)疫苗、藥物和診斷方法在遇到新毒株時不會失效。
您已閱讀9%(366字),剩餘91%(3630字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。